Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients

被引:0
作者
Akitaka Nomura
Yoshihiro Maruo
Takashi Taga
Yoshihiro Takeuchi
机构
[1] Shiga University of Medical Science,Department of Pediatrics
来源
Pediatric Research | 2016年 / 80卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:252 / 257
页数:5
相关论文
共 50 条
  • [31] Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia
    Bai, Jie
    Luo, Lei
    Liu, Shuang
    Liang, Chen
    Bai, Li
    Chen, Yu
    Zheng, Sujun
    Duan, Zhongping
    FRONTIERS IN GENETICS, 2019, 10
  • [32] COMBINED EFFECTS OF UGT1A1 AND SLCO1B1 VARIANTS ON CHINESE ADULT MILD UNCONJUGATED HYPERBILIRUBINEMIA
    Bai, Jie
    Luo, Lei
    Liu, Shuang
    Liang, Chen
    Bai, Li
    Yu, Chen, Sr.
    Zheng, Sujun
    Duan, Zhongping
    HEPATOLOGY, 2019, 70 : 1180A - 1180A
  • [33] Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Heydari, Mohammad Reza
    Fardaei, Majid
    FRONTIERS IN PEDIATRICS, 2020, 7
  • [34] Underestimation of the contribution of 211 G to A variation in UGT1A1 to neonatal hyperbilirubinemia in China Reply
    Yang, Lin
    Mei, Hongfang
    Lu, Yulan
    Zhou, Wenhao
    JOURNAL OF PEDIATRICS, 2022, 245 : 252 - 253
  • [35] Influence of UGT1A1*6,*27, and*28 Polymorphisms on Nilotinib-induced Hyperbilirubinemia in Japanese Patients with Chronic Myeloid Leukemia
    Abumiya, Maiko
    Takahashi, Naoto
    Niioka, Takenori
    Kameoka, Yoshihiro
    Fujishima, Naohito
    Tagawa, Hiroyuki
    Sawada, Kenichi
    Miura, Masatomo
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (06) : 449 - 454
  • [36] Severe Neonatal Hyperbilirubinemia and UGT1A1 Promoter Polymorphism
    Travan, Laura
    Lega, Sara
    Crovella, Sergio
    Montico, Marcella
    Panontin, Elisa
    Demarini, Sergio
    JOURNAL OF PEDIATRICS, 2014, 165 (01) : 42 - 45
  • [37] UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China
    Hui Yang
    Fen Lin
    Zi-kai Chen
    Lin Zhang
    Jia-Xin Xu
    Yong-Hao Wu
    Jing-Ying Gu
    Yu-Bin Ma
    Jian-Dong Li
    Li-Ye Yang
    BMC Pediatrics, 21
  • [38] UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia
    Singer, J. B.
    Shou, Y.
    Giles, F.
    Kantarjian, H. M.
    Hsu, Y.
    Robeva, A. S.
    Rae, P.
    Weitzman, A.
    Meyer, J. M.
    Dugan, M.
    Ottmann, O. G.
    LEUKEMIA, 2007, 21 (11) : 2311 - 2315
  • [39] Reply to: Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient
    Cattaneo, Daniele
    Iurlo, Alessandra
    ANTI-CANCER DRUGS, 2025, 36 (06)
  • [40] UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China
    Yang, Hui
    Lin, Fen
    Chen, Zi-kai
    Zhang, Lin
    Xu, Jia-Xin
    Wu, Yong-Hao
    Gu, Jing-Ying
    Ma, Yu-Bin
    Li, Jian-Dong
    Yang, Li-Ye
    BMC PEDIATRICS, 2021, 21 (01)